CoChat

A Peptide Inhibitor of c-Jun N-Terminal Kinase for the Treatment of Endotoxin-Induced Uveitis

Touchard, Elodie, Omri, Samy, Naud, Marie-Christine, Berdugo, Marianne, Deloche, Catherine, Abadie, Claire, Jonet, Laurent, Jeanny, Jean-Claude, Crisanti, Patricia, de Kozak, Yvonne, Combette, Jean-Marc, Behar-Cohen, Francine · 2010 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

PURPOSE: To evaluate the effect of XG-102 (formerly D-JNKI1), a TAT-coupled dextrogyre peptide that selectively inhibits the c-Jun N-terminal kinase, in the treatment of endotoxin-induced uveitis (EIU). METHODS: EIU was induced in Lewis rats by LPS injection. XG-102 was administered at the time of LPS challenge. The ocular biodistribution of XG-102 was evaluated using immunodetection at 24 hours after either 20 microg/kg IV (IV) or 0.2 microg/injection intravitreous (IVT) administrations in healthy or uveitic eyes. The effect of XG-102 on EIU was evaluated using clinical scoring, infiltration cell quantification, inducible nitric oxide synthase (iNOS) expression and immunohistochemistry, and cytokines and chemokines kinetics at 6, 24, and 48 hours using multiplex analysis on ocular media. Control EIU eyes received vehicle injection IV or IVT. The effect of XG-102 on c-Jun phosphorylation in EIU was evaluated by Western blot in eye tissues. RESULTS: After IVT injection, XG-102 was internalized in epithelial cells from iris/ciliary body and retina and in glial and microglial cells in both healthy and uveitic eyes. After IV injection, XG-102 was concentrated primarily in inflammatory cells of uveitic eyes. Using both routes of administration, XG-102 significantly inhibited clinical signs of EIU, intraocular cell infiltration, and iNOS expression together with reduced phosphorylation of c-Jun. The anti-inflammatory effect of XG-102 was mediated by iNOS, IFN-gamma, IL-2, and IL-13. CONCLUSIONS: This is the first evidence that interfering with the JNK pathway can reduce intraocular inflammation. Local administration of XG-102, a clinically evaluated peptide, may have potential for treating uveitis.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.09-4733

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 44

Metadata

Authors
Touchard, E., Omri, S., Naud, M.-C., Berdugo, M., Deloche, C., Abadie, C., Jonet, L., Jeanny, J.-C., Crisanti, P., de Kozak, Y., Combette, J.-M., & Behar-Cohen, F.
Affiliations
  • Inserm (FR)
  • RibOvax Biotechnologies S.A., Geneva, Switzerland; and
  • From the INSERM, U872 Physiopathology of Ocular Diseases/Therapeutic Innovations, Paris, France; 2Centre de Recherche des Cordeliers, Université Pierre et Marie Curie—Paris6, UMR S 872, Paris, France; 3Université Paris Descartes, UMR S 872, Paris, France;
Corresponding author
  • Touchard, Elodie
  • Omri, Samy
  • Naud, Marie-Christine
  • Berdugo, Marianne
  • Deloche, Catherine
  • Abadie, Claire
  • Jonet, Laurent
  • Jeanny, Jean-Claude
  • Crisanti, Patricia
  • Combette, Jean-Marc
Venue
Investigative Opthalmology & Visual Science
Published
2010-09-01
Volume
51
Issue
9
Pages
4683
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2069483338
Cited by
43
References
30
Citations by year
2023: 3 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 3 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 4
FWCI
4.20
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
endotoxin-induced uveitis, intravitreal administration, inducible nitric oxide synthase, c-Jun phosphorylation, intraocular inflammation, cytokines and chemokines, interferon-gamma, interleukin-2, IL-13, lipopolysaccharide, uveitis treatment
MeSH terms
Animals, Disease Models, Animal, Drug Combinations, Female, Injections, Intravenous, Lipopolysaccharides, Oils, Peptides, Phenols, Rats, Inbred Lew, Tissue Distribution, Uveitis, Vitreous Body, Signal Transduction, Down-Regulation, Cytokines, Chemokines, Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating), JNK Mitogen-Activated Protein Kinases, Rats, Nitric Oxide Synthase Type II, Injections, Intraocular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.